Inflammatory illness: Why the next wave of antidepressants may target the immune system

From C-Reactive Protein to Interleukin-6 to Interleukin-1

(2016) Paul M Ridker   CIRCULATION RESEARCH

Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients

(2016) Annamaria Cattaneo et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life

(2014) Golam M. Khandaker et al.   JAMA Psychiatry

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response

(2012) Timothy R. Powell et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

(2012) Charles L. Raison et al.   JAMA Psychiatry

Association of high-sensitivity C-reactive protein with de novo major depression

(2010) Julie A. Pasco et al.   BRITISH JOURNAL OF PSYCHIATRY

A Meta-Analysis of Cytokines in Major Depression

(2009) Yekta Dowlati et al.   BIOLOGICAL PSYCHIATRY